Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease
Wenjie Liu, Limeng Wu, Wenwu Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114689-114689
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 78
Syntheses, reactivity, and biological applications of coumarins
Andrea Citarella, Serena Vittorio, Christian Dank, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 18
Recent advances on biologically active coumarin-based hybrid compounds
Metin Yıldırım, Samet Poyraz, Mehmet Erşatır
Medicinal Chemistry Research (2023) Vol. 32, Iss. 4, pp. 617-642
Closed Access | Times Cited: 37
Natural product-based pharmacological studies for neurological disorders
Vivek Puri, Neha Kanojia, Ameya Sharma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects
Zimeng Cheng, Tianyue Han, Jingtong Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116065-116065
Closed Access | Times Cited: 15
Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design
Manish Tripathi, Bhagwati Bhardwaj, Digambar Kumar Waiker, et al.
Journal of Molecular Structure (2023) Vol. 1286, pp. 135517-135517
Closed Access | Times Cited: 14
BACE1 Inhibitors for Alzheimer’s Disease: Current Challenges and Future Perspectives
Judite R.M. Coimbra, Rosa Resende, José B.A. Custódio, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S53-S78
Closed Access | Times Cited: 5
The role of PI3K signaling pathway in Alzheimer’s disease
Jingying Pan, Yao Qi, Yankai Wang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
Lipoic acid scaffold applications in the design of multitarget-directed ligands against Alzheimer’s disease
Mohammad Amin Manavi, Mona Nourhashemi, Saeed Emami, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108241-108241
Closed Access
Synthesis and Biological Evaluation of Coumarin Triazoles as Dual Inhibitors of Cholinesterases and β-Secretase
Ankita Sharma, Sandip B. Bharate
ACS Omega (2023) Vol. 8, Iss. 12, pp. 11161-11176
Open Access | Times Cited: 12
Photoredox-Catalyzed Redox-Neutral Decarboxylative C–H Acylations of Coumarins with α-Keto Acid
Bin Sun, Yingying Wang, Jia‐Yin Wang, et al.
Organic Letters (2023) Vol. 25, Iss. 14, pp. 2466-2470
Closed Access | Times Cited: 11
Design, Synthesis and Anticholinesterase Activity of Coumarin‐1,3,5‐triazine Derivatives
Xiaoqing Zhang, Jing Wang, Jing‐Pei Zou, et al.
ChemistrySelect (2024) Vol. 9, Iss. 3
Closed Access | Times Cited: 4
Design, synthesis, and evaluation of dual‐target inhibitors for the treatment of Alzheimer's disease
Jingfang Zhai, Canhua Hao, Xiaojing Wang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 4
Investigating the Impact of Origins on the Quality Characteristics of Celery Seeds Based on Metabolite Analysis through HS-GC-IMS, HS-SPME-GC-MS and UPLC-ESI-MS/MS
Jun Yan, Lizhong He, Huang Zhiwu, et al.
Foods (2024) Vol. 13, Iss. 10, pp. 1428-1428
Open Access | Times Cited: 4
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Playing Around the Coumarin Core in the Discovery of Multimodal Compounds Directed at Alzheimer’s-Related Targets: A Recent Literature Overview
Mariagrazia Rullo, Gabriella La Spada, Angela Stefanachi, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 891-891
Open Access
Discovery of novel hybrids containing clioquinol−1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease
Xinnan Li, Tiantian Li, Pengfei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114841-114841
Open Access | Times Cited: 16
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Yuxing Yao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115120-115120
Closed Access | Times Cited: 10
Discovery of novel deoxyvasicinone derivatives with benzenesulfonamide substituents as multifunctional agents against Alzheimer's disease
Shuanghong Dong, Jucheng Xia, Fang Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116013-116013
Closed Access | Times Cited: 9
Recent updates in chemistry of Alzheimer's: Synthetic molecules
Deepak K. Lokwani, Sangita R. Chavan, Vinod G. Ugale, et al.
Elsevier eBooks (2024), pp. 33-46
Closed Access | Times Cited: 3
The molecular effects underlying the pharmacological activities of daphnetin
Zhifeng Wei, Na Wei, Long Su, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Naturally Inspired Coumarin Derivatives in Alzheimer’s Disease Drug Discovery: Latest Advances and Current Challenges
Rebecca Orioli, Federica Belluti, Silvia Gobbi, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3514-3514
Open Access | Times Cited: 3
Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment
Wenjie Liu, Liting Tian, Limeng Wu, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106168-106168
Closed Access | Times Cited: 15
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration
Emanuela Berrino, Simone Carradori, Fabrizio Carta, et al.
Antioxidants (2023) Vol. 12, Iss. 12, pp. 2044-2044
Open Access | Times Cited: 8
Rational design, synthesis and computational studies of multi-targeted anti-Alzheimer’s agents integrating coumarin scaffold
Menna M. A. Abd El‐Mageed, Manal Abdel Fattah Ezzat, Shaimaa A. Moussa, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108024-108024
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top